Nabriva Therapeutics plc

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$5.7M

453 transactions

Summary

Nabriva Therapeutics plc is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $1.2MSales: $4.3M20 insiders

Date	Insider	Type	Value
2023-01-29	Schroeder Theodore R	F	$646.5
2023-01-29	Gelone Steven P.	F	$210
2022-09-06	Schroeder Theodore R(Chief Executive Officer)	F	$36
2022-10-06	Schroeder Theodore R(Chief Executive Officer)	F	$24.48
2022-11-06	Schroeder Theodore R(Chief Executive Officer)	F	$22.4
2022-12-06	Schroeder Theodore R(Chief Executive Officer)	F	$18.18
2023-01-06	Schroeder Theodore R(Chief Executive Officer)	F	$14.3
2022-09-06	Gelone Steven P.(President and COO)	F	$14.24
2022-10-31	Schroeder Theodore R(Chief Executive Officer)	F	$12.7
2022-11-30	Schroeder Theodore R(Chief Executive Officer)	F	$11.25
2022-10-06	Gelone Steven P.(President and COO)	F	$10.88
2022-09-30	Schroeder Theodore R(Chief Executive Officer)	F	$10.4
2022-12-31	Schroeder Theodore R(Chief Executive Officer)	F	$9.45
2022-11-06	Gelone Steven P.(President and COO)	F	$8.96
2022-12-06	Gelone Steven P.(President and COO)	F	$8.08
2022-10-31	Gelone Steven P.(President and COO)	F	$7.62
2022-11-30	Gelone Steven P.(President and COO)	F	$6.75
2023-01-06	Gelone Steven P.(President and COO)	F	$6.5
2022-09-30	Gelone Steven P.(President and COO)	F	$6.24
2022-12-31	Gelone Steven P.(President and COO)	F	$5.67

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Nabriva Therapeutics plc — Contributions, Lobbying & Contracts | Poliscope